Insights

Acquisition Growth Post-acquisition integration readiness presents a sales opportunity for IT, data management, and professional services to align Health Logic Interactive assets with Marizyme’s cardiac-care portfolio and broaden the combined customer base.

Intl Distribution Existing international distribution with Abdera Financial in Chile signals channels for Latin America expansion; opportunities to partner on regulatory support, channel sales, and localized service for DuraGraft and related products.

Cardiac Care Focus Marizyme’s focus on reducing ischemia-reperfusion injury in tissue grafting and organ transplant suggests upsell and cross-sell of surgical training, workflow integration, and value-added services to transplant centers and cardiothoracic units.

Analytics Ready A tech stack centered on Google Cloud and data visualization tools indicates a fit for enterprise-grade analytics, dashboarding, and secure data sharing with hospitals and distributors, suggesting a need for data integration and HIPAA-compliant hosting solutions.

Growth Opportunities With modest revenue and funding, a compact, agile team may respond well to strategic partnerships, licensing or co-development deals, and joint go-to-market efforts with medical technology providers.

Marizyme Inc. Tech Stack

Marizyme Inc. uses 8 technology products and services including GoDaddy Website Builder, RSS, Twemoji, and more. Explore Marizyme Inc.'s tech stack below.

  • GoDaddy Website Builder
    Content Management System
  • RSS
    Content Management System
  • Twemoji
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Element UI
    Javascript Frameworks
  • YouTube
    Video Players
  • X-Content-Type-Options
    Web & Portal Technology
  • WP Google Map Plugin
    Web Platform Extensions

Media & News

Marizyme Inc.'s Email Address Formats

Marizyme Inc. uses at least 1 format(s):
Marizyme Inc. Email FormatsExamplePercentage
FLast@marizyme.comJDoe@marizyme.com
100%

Frequently Asked Questions

What is Marizyme Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Marizyme Inc.'s official website is marizyme.com and has social profiles on LinkedInCrunchbase.

What is Marizyme Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Marizyme Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Marizyme Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Marizyme Inc. has approximately 11 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer: N. C. N. L. W. C.Chief Pilot: M. C.Independent Chairman: V. D.. Explore Marizyme Inc.'s employee directory with LeadIQ.

What industry does Marizyme Inc. belong to?

Minus sign iconPlus sign icon
Marizyme Inc. operates in the Biotechnology Research industry.

What technology does Marizyme Inc. use?

Minus sign iconPlus sign icon
Marizyme Inc.'s tech stack includes GoDaddy Website BuilderRSSTwemojiGoogle CloudElement UIYouTubeX-Content-Type-OptionsWP Google Map Plugin.

What is Marizyme Inc.'s email format?

Minus sign iconPlus sign icon
Marizyme Inc.'s email format typically follows the pattern of FLast@marizyme.com. Find more Marizyme Inc. email formats with LeadIQ.

How much funding has Marizyme Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Marizyme Inc. has raised $5.6M in funding. The last funding round occurred on Aug 04, 2020 for $5.6M.

When was Marizyme Inc. founded?

Minus sign iconPlus sign icon
Marizyme Inc. was founded in 2007.
Marizyme Inc. logo

Marizyme Inc.

Biotechnology ResearchFlorida, United States11-50 Employees

Marizyme Inc. is a Jupiter, Florida-based biotechnology company focused on advancing cardiac care through medical technologies. The company develops products intended to reduce ischemia-reperfusion injury associated with tissue grafting, organ transplantation, and other surgical indications. Operating on a global scale, it positions itself within the biotechnology and medical technology sectors as a developer of therapies or devices that mitigate surgical injury. Its primary customers are healthcare providers, surgeons, and hospitals involved in tissue grafting and organ transplant procedures. In December 2021, Marizyme completed the acquisition of Health Logic Interactive, signaling an expansion of its strategic footprint.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $5.6M

    Marizyme Inc. has raised a total of $5.6M of funding over 1 rounds. Their latest funding round was raised on Aug 04, 2020 in the amount of $5.6Mas a series_unknown.

  • $1M$10M

    Marizyme Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5.6M

    Marizyme Inc. has raised a total of $5.6M of funding over 1 rounds. Their latest funding round was raised on Aug 04, 2020 in the amount of $5.6Mas a series_unknown.

  • $1M$10M

    Marizyme Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.